STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serve… Read more
STAAR Surgical Company (STAA) - Total Assets
Latest total assets as of September 2025: $456.36 Million USD
Based on the latest financial reports, STAAR Surgical Company (STAA) holds total assets worth $456.36 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
STAAR Surgical Company - Total Assets Trend (1988–2024)
This chart illustrates how STAAR Surgical Company’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
STAAR Surgical Company - Asset Composition Analysis
Current Asset Composition (December 2024)
STAAR Surgical Company's total assets of $456.36 Million consist of 72.2% current assets and 27.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 28.3% |
| Accounts Receivable | $79.26 Million | 15.6% |
| Inventory | $43.30 Million | 8.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $1.79 Million | 0.4% |
Asset Composition Trend (1988–2024)
This chart illustrates how STAAR Surgical Company's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: STAAR Surgical Company's current assets represent 72.2% of total assets in 2024, an increase from 38.5% in 1988.
- Cash Position: Cash and equivalents constituted 28.3% of total assets in 2024, up from 0.6% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1988.
- Asset Diversification: The largest asset category is accounts receivable at 15.6% of total assets.
STAAR Surgical Company Competitors by Total Assets
Key competitors of STAAR Surgical Company based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
STAAR Surgical Company - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - STAAR Surgical Company generates 0.62x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - STAAR Surgical Company is currently not profitable relative to its asset base.
STAAR Surgical Company - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.21 | 5.99 | 5.25 |
| Quick Ratio | 4.35 | 5.38 | 4.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $259.57 Million | $ 330.76 Million | $ 175.18 Million |
STAAR Surgical Company - Advanced Valuation Insights
This section examines the relationship between STAAR Surgical Company's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.30 |
| Latest Market Cap to Assets Ratio | 1.08 |
| Asset Growth Rate (YoY) | 4.3% |
| Total Assets | $509.52 Million |
| Market Capitalization | $548.73 Million USD |
Valuation Analysis
Above Book Valuation: The market values STAAR Surgical Company's assets above their book value (1.08 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: STAAR Surgical Company's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for STAAR Surgical Company (1988–2024)
The table below shows the annual total assets of STAAR Surgical Company from 1988 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $509.52 Million | +4.26% |
| 2023-12-31 | $488.69 Million | +16.68% |
| 2022-12-31 | $418.82 Million | +21.12% |
| 2021-12-31 | $345.78 Million | +34.33% |
| 2020-12-31 | $257.42 Million | +24.04% |
| 2019-12-31 | $207.52 Million | +24.01% |
| 2018-12-31 | $167.34 Million | +146.33% |
| 2017-12-31 | $67.93 Million | +3.80% |
| 2016-12-31 | $65.44 Million | +3.95% |
| 2015-12-31 | $62.95 Million | +6.86% |
| 2014-12-31 | $58.91 Million | -4.88% |
| 2013-12-31 | $61.93 Million | +13.10% |
| 2012-12-31 | $54.76 Million | +11.74% |
| 2011-12-31 | $49.01 Million | +20.75% |
| 2010-12-31 | $40.59 Million | -30.84% |
| 2009-12-31 | $58.68 Million | +11.60% |
| 2008-12-31 | $52.58 Million | -2.95% |
| 2007-12-31 | $54.18 Million | +13.42% |
| 2006-12-31 | $47.77 Million | -9.45% |
| 2005-12-31 | $52.76 Million | +1.50% |
| 2004-12-31 | $51.97 Million | +10.07% |
| 2003-12-31 | $47.22 Million | +4.42% |
| 2002-12-31 | $45.22 Million | -31.28% |
| 2001-12-31 | $65.81 Million | -17.90% |
| 2000-12-31 | $80.15 Million | -6.03% |
| 1999-12-31 | $85.30 Million | +16.37% |
| 1998-12-31 | $73.30 Million | +17.47% |
| 1997-12-31 | $62.40 Million | +22.11% |
| 1996-12-31 | $51.10 Million | +31.70% |
| 1995-12-31 | $38.80 Million | +34.26% |
| 1994-12-31 | $28.90 Million | +53.72% |
| 1993-12-31 | $18.80 Million | +46.88% |
| 1992-12-31 | $12.80 Million | +36.17% |
| 1991-12-31 | $9.40 Million | -11.32% |
| 1990-12-31 | $10.60 Million | -20.30% |
| 1989-12-31 | $13.30 Million | -17.39% |
| 1988-12-31 | $16.10 Million | -- |